Literature DB >> 18375823

Nuclear receptors and inflammatory diseases.

Kun Wang1, Yu-Jui Yvonne Wan.   

Abstract

It is well known that the steroid hormone glucocorticoid and its nuclear receptor regulate the inflammatory process, a crucial component in the pathophysiological process related to human diseases that include atherosclerosis, obesity and type II diabetes, inflammatory bowel disease, Alzheimer's disease, multiple sclerosis, and liver tumors. Growing evidence demonstrates that orphan and adopted orphan nuclear receptors, such as peroxisome proliferator-activated receptors, liver x receptors, the farnesoid x receptor, NR4As, retinoid x receptors, and the pregnane x receptor, regulate the inflammatory and metabolic profiles in a ligand-dependent or -independent manner in human and animal models. This review summarizes the regulatory roles of these nuclear receptors in the inflammatory process and the underlying mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375823      PMCID: PMC3991236          DOI: 10.3181/0708-MR-231

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  148 in total

1.  Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent.

Authors:  Dallas C Jones; Xiaohong Ding; Raymond A Daynes
Journal:  J Biol Chem       Date:  2001-11-28       Impact factor: 5.157

2.  Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation.

Authors:  S Kippenberger; S M Loitsch; M Grundmann-Kollmann; S Simon; T A Dang; K Hardt-Weinelt; R Kaufmann; A Bernd
Journal:  J Invest Dermatol       Date:  2001-12       Impact factor: 8.551

Review 3.  General principles and pharmacology of biologics in inflammatory bowel disease.

Authors:  Patricia L Kozuch; Stephen B Hanauer
Journal:  Gastroenterol Clin North Am       Date:  2006-12       Impact factor: 3.806

4.  PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells.

Authors:  Yves Rival; Nathalie Benéteau; Thierry Taillandier; Mylène Pezet; Elisabeth Dupont-Passelaigue; Jean François Patoiseau; Didier Junquéro; Francis C Colpaert; André Delhon
Journal:  Eur J Pharmacol       Date:  2002-01-25       Impact factor: 4.432

Review 5.  Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes.

Authors:  W A Hsueh; S Jackson; R E Law
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

Review 6.  [The peroxisome-proliferator-activated gamma receptor and chronic inflammatory bowel disease (PPARgamma and IBD)].

Authors:  Christel Rousseaux; Pierre Desreumaux
Journal:  J Soc Biol       Date:  2006

7.  PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages.

Authors:  John S Welch; Mercedes Ricote; Taro E Akiyama; Frank J Gonzalez; Christopher K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

8.  Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin-1beta.

Authors:  Renaud Le Bouquin; Alain Lugnier; Nelly Frossard; Françoise Pons
Journal:  Fundam Clin Pharmacol       Date:  2004-04       Impact factor: 2.748

9.  Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase.

Authors:  Magdalena Sastre; Ilse Dewachter; Gary E Landreth; Timothy M Willson; Thomas Klockgether; Fred van Leuven; Michael T Heneka
Journal:  J Neurosci       Date:  2003-10-29       Impact factor: 6.167

Review 10.  The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences.

Authors:  Jean-Marc Pascussi; Sabine Gerbal-Chaloin; Cédric Duret; Martine Daujat-Chavanieu; Marie-José Vilarem; Patrick Maurel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

View more
  29 in total

1.  Bupropion Ameliorates Acetic Acid-Induced Colitis in Rat: the Involvement of the TLR4/NF-kB Signaling Pathway.

Authors:  Amir Rashidian; Pegah Dejban; Kiana Karami Fard; Alireza Abdollahi; Mohsen Chamanara; Ahmadreza Dehpour; Amin Hasanvand
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

2.  Relevance of nuclear receptor expression in a Tchreg cell line, HOZOT: RXRα and PPARγ negatively regulate IFN-γ production.

Authors:  Motoyuki Suzuki; Makoto Takeuchi; Kazue Tsuji-Takayama; Akira Harashima; Takeshi Otani; Terumasa Toraya; Hiroki Kakuta; Fumiyuki Yamasaki; Shuji Nakamura; Masayoshi Kibata
Journal:  Results Immunol       Date:  2012-08-19

3.  Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity.

Authors:  Prasant Kumar Jena; Lili Sheng; Jacopo Di Lucente; Lee-Way Jin; Izumi Maezawa; Yu-Jui Yvonne Wan
Journal:  FASEB J       Date:  2018-01-10       Impact factor: 5.191

4.  Retinoic Acid-mediated Nuclear Receptor Activation and Hepatocyte Proliferation.

Authors:  Nathan Bushue; Yu-Jui Yvonne Wan
Journal:  J Exp Clin Med       Date:  2009-12

Review 5.  The interaction between HCV and nuclear receptor-mediated pathways.

Authors:  Zoe Raglow; Carly Thoma-Perry; Richard Gilroy; Yu-Jui Yvonne Wan
Journal:  Pharmacol Ther       Date:  2011-05-18       Impact factor: 12.310

Review 6.  The Impact of Carnitine on Dietary Fiber and Gut Bacteria Metabolism and Their Mutual Interaction in Monogastrics.

Authors:  Abdallah Ghonimy; Dong Ming Zhang; Mohammed Hamdy Farouk; Qiuju Wang
Journal:  Int J Mol Sci       Date:  2018-03-28       Impact factor: 5.923

Review 7.  Hepatic metabolism of retinoids and disease associations.

Authors:  Yohei Shirakami; Seung-Ah Lee; Robin D Clugston; William S Blaner
Journal:  Biochim Biophys Acta       Date:  2011-07-01

Review 8.  The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease.

Authors:  Maja Stojancevic; Karmen Stankov; Momir Mikov
Journal:  Can J Gastroenterol       Date:  2012-09       Impact factor: 3.522

Review 9.  Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research.

Authors:  P Porcu; A M Barron; C A Frye; A A Walf; S-Y Yang; X-Y He; A L Morrow; G C Panzica; R C Melcangi
Journal:  J Neuroendocrinol       Date:  2016-02       Impact factor: 3.627

10.  The protective role of pregnane X receptor in lipopolysaccharide/D-galactosamine-induced acute liver injury.

Authors:  Kun Wang; Ivan Damjanov; Yu-Jui Yvonne Wan
Journal:  Lab Invest       Date:  2009-12-07       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.